Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by Zonulolysis and cataract

被引:18
|
作者
Kralinger, MT
Kieselbach, GF
Voigt, M
Hayden, B
Hernandez, E
Fernandez, V
Pare, JM
机构
[1] Med Univ Innsbruck, Klin Augenheilkunde & Optometrie, Dept Ophthalmol, AT-6020 Innsbruck, Austria
[2] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Ophthalm Biophys Ctr, Miami, FL 33152 USA
[3] Humboldt Univ, Charite Hosp, Ophthal Clin Virchow, Berlin, Germany
[4] Univ Liege, CHU Sart Tilman, Dept Ophthalmol, Liege, Belgium
[5] Univ Paris, Hop Hotel Dieu, F-75252 Paris, France
关键词
dispase; experimental model; intravitreal injection; proliferative; vitreoretinopathy; cataract; zonulolysis;
D O I
10.1159/000093073
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81 % of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 50 条
  • [1] A mouse model of proliferative vitreoretinopathy induced by dispase
    Soler, MVC
    Gallo, JE
    Dodds, RA
    Suburo, AM
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (05) : 491 - 504
  • [2] EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY INDUCED BY INTRAVITREAL MICROPARTICLES
    ALGVERE, P
    MARTINI, B
    INTERNATIONAL OPHTHALMOLOGY, 1985, 8 (02) : 98 - 98
  • [3] Effects of Substance P on Mouse Model of Proliferative Vitreoretinopathy Induced by Dispase
    Yu, Seung-Young
    Kim, Eung Suk
    Son, Bo Kwon
    Kwak, Hyung-Woo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] CATARACT EXTRACTION WITH LIMITED ENZYMATIC ZONULOLYSIS
    HILL, HF
    ARCHIVES OF OPHTHALMOLOGY, 1966, 75 (01) : 89 - &
  • [5] Effect of intravitreal suramin on a rabbit model of proliferative vitreoretinopathy
    Hassan, T
    Pendergast, SD
    Hartzer, M
    Cheng, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1824 - 1824
  • [6] Intravitreal STI571 inhibits development of proliferative vitreoretinopathy in an experimental rabbit model
    Velez, G
    Kazlauskas, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [7] The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy
    Kuo, Hsi-Kung
    Chen, Yi-Hao
    Wu, Pei-Chang
    Kuo, Yu-Hsia
    OPHTHALMOLOGICA, 2015, 233 (3-4) : 198 - 203
  • [8] An experimental porcine model for proliferative vitreoretinopathy
    Kaiser, PK
    Kamei, M
    Lewis, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S951 - S951
  • [9] Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
    Benner, Jeffrey David
    Dao, David
    Butler, John W.
    Hamill, Kelli, I
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
  • [10] Effect of intravitreal plasmin on a model of proliferative vitreoretinopathy in the rabbit.
    Hartzer, M
    Pendergast, S
    Ross, R
    Dailey, W
    Cheng, M
    Stec, L
    Trese, M
    Williams, GA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 5465 - 5465